EFSp-GFP-YAP (S94A) Citations (4)
Originally described in: Binary pan-cancer classes with distinct vulnerabilities defined by pro- or anti-cancer YAP/TEAD activity.Pearson JD, Huang K, Pacal M, McCurdy SR, Lu S, Aubry A, Yu T, Wadosky KM, Zhang L, Wang T, Gregorieff A, Ahmad M, Dimaras H, Langille E, Cole SPC, Monnier PP, Lok BH, Tsao MS, Akeno N, Schramek D, Wikenheiser-Brokamp KA, Knudsen ES, Witkiewicz AK, Wrana JL, Goodrich DW, Bremner R Cancer Cell. 2021 Jul 13. pii: S1535-6108(21)00338-X. doi: 10.1016/j.ccell.2021.06.016. PubMed Journal
Articles Citing EFSp-GFP-YAP (S94A)
| Articles |
|---|
| Lentiviral-mediated ectopic expression of YAP and TAZ in YAP(off) cancer cell lines. Pearson JD, Bremner R. STAR Protoc. 2021 Oct 1;2(4):100870. doi: 10.1016/j.xpro.2021.100870. eCollection 2021 Dec 17. PubMed |
Destabilized reporters for background-subtracted, chemically-gated, and multiplexed deep-tissue imaging.
Yun J, Huang Y, Miller ADC, Chang BL, Baldini L, Dhanabalan KM, Li E, Li H, Mukherjee A.
Chem Sci. 2024 Jun 4;15(28):11108-11121. doi: 10.1039/d4sc00377b. eCollection 2024 Jul 17.
PubMed
Associated Plasmids |
| Netrin-1 and UNC5B Cooperate with Integrins to Mediate YAP-Driven Cytostasis. Pearson JD, Huang K, Dela Pena LG, Ducarouge B, Mehlen P, Bremner R. Cancer Res Commun. 2024 Sep 1;4(9):2374-2383. doi: 10.1158/2767-9764.CRC-24-0101. PubMed |
| MED12 mutation induces RTK inhibitor resistance in NSCLC via MEK/ERK pathway activation by inflammatory cytokines. Ryu HM, Kim D, Choi JY, Yoon S, Lee HS, Park JE, Lee E, Sung Y, Lee CH, Lee EY, Kim W, Seo S, Kim SW, Park KS, Lee DH. Cell Mol Life Sci. 2025 Aug 20;82(1):314. doi: 10.1007/s00018-025-05791-w. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.